0001562180-23-008573.txt : 20231228 0001562180-23-008573.hdr.sgml : 20231228 20231228163930 ACCESSION NUMBER: 0001562180-23-008573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231226 FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Jonathan C CENTRAL INDEX KEY: 0001655016 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 231523131 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-12-26 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001655016 Fox Jonathan C C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 true false false false false Common Stock 2023-12-26 4 P false 10857.00 9.2989 A 10857.00 D /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C 2023-12-28